ARS Pharmaceuticals, Inc. (SPRY)
(Real Time Quote from BATS)
$13.57 USD
+0.03 (0.22%)
Updated Aug 16, 2024 01:04 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (94 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.58 | 9.99 |
Current Quarter Estimate | -0.18 | -1.03 | 61.00 |
Year Ago Quarter Estimate | -0.16 | -0.07 | 54.84 |
Next Quarter Estimate | -0.25 | -1.82 | 63.00 |
Next Year Estimate | -0.67 | 12.72 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -15.79 | 18.90 | 15.67 |
Next Year | -1.52 | 16.10 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 22.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -9.82 |
Price/Book (MRQ) | 6.10 | 1.47 |
Price/Cash Flow (MRFY) | NA | 8.80 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -35.91% |
Return on Equity (TTM) | -19.77% | -39.73% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.